Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Total 13F shares
-
62,661
-
Share change
-
-9,324
-
Total reported value
-
$226,832
-
Price per share
-
$3.62
-
Number of holders
-
8
-
Value change
-
-$33,859
-
Number of buys
-
1
-
Number of sells
-
5
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q3 2023
As of 30 Sep 2023,
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,661 shares.
The largest 8 holders included
GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, Activest Wealth Management, COMPASS GROUP LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, and CLEAR STREET LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.